Health Care & Life Sciences » Pharmaceuticals | Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
166.44 M
Public Float
104.73 M
Rigel Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.39
Market Cap
$428.01 M
Shares Outstanding
167.19 M
Public Float
159.59 M

Profile

Address
1180 Veterans Boulevard
South San Francisco California 94080
United States
Employees -
Website http://www.rigel.com
Updated 07/08/2019
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. It focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms.

Financials

View All

Gary A. Lyons
Chairman
Gregg Anthony Lapointe
Independent Director